TP53 and non-small cell lung carcinoma: In one study, H1299 non-small cell lung cancer (NSCLC) cells, which are null in p53 and deficient in p16INK4, were induced into senescence by camptothecin and other chemotherapeutic agents such as etoposide and cisplatin [71].